幹細胞療法市場：按細胞來源、應用、最終用戶和地區分類

Stem Cell Therapy Market, By Cell Source, By Application, By End User, By Geography

出版日期: 2026年03月31日 | 出版商:

Coherent Market Insights | 英文 153 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，幹細胞治療市場規模將達到228.9億美元，2033年將達975億美元。預計從2026年到2033年，該市場將以23.0%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	228.9億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	23.00%	2033年市場規模預測：	975億美元

幹細胞療法是再生醫學領域一個極具前景的新興方向，它利用幹細胞及其衍生物來修復或再生受損的組織和細胞。幹細胞存在於所有人體內，出生後不久就已存在。它們具有獨特的自我更新能力，能夠透過細胞分裂分化成多種特化細胞。這些細胞具有巨大的潛力，可透過移植和組織再生來治療許多不治之症。幹細胞研究旨在利用幹細胞的天然力量，開發能夠治療多種疾病的療法，包括癌症、糖尿病、心臟病、骨關節炎和神經系統疾病。

市場動態

全球幹細胞治療市場的成長受到多種因素的驅動，包括慢性疾病盛行率上升、幹細胞療法成功率提高、再生醫學快速發展、幹細胞療法研發投入增加以及新治療方法核准。然而，幹細胞研發和治療應用的高昂成本，以及與胚胎幹細胞相關的倫理問題，可能會阻礙市場成長。新型幹細胞來源的出現、用於高效幹細胞生產的先進技術平台的開發，以及人工智慧在加速個人化幹細胞療法開發方面的應用，可能為未來的市場成長帶來機會。在全球範圍內提供價格合理的幹細胞療法，並開發高效的幹細胞庫技術，將有助於滿足未被滿足的醫療需求，並擴大市場覆蓋範圍。

本次調查的主要特點

本研究確定了各細分市場的潛在收入成長機會，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數創建了全球幹細胞治療市場主要公司的概況：公司亮點、產品系列、主要特徵、財務表現和策略。
本研究涵蓋的主要公司包括 Osiris Therapeutics, Inc.、Kolon TissueGene, Inc.、JCR Pharmaceuticals Co., Ltd.、Anterogen Co. Ltd.、Pharmicell Co., Inc.、Stemedica Cell Technologies, Inc.、Magellan、Medipost Co., Ltd.、Athersys Inc.、Corormert. Biomedicine Group、ANTEROGEN. CO, LTD.、NuVasive Inc.、RTI Surgical 和 AlloSource。
本報告中的見解將使各公司的行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球幹細胞治療市場涵蓋了許多相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球幹細胞治療市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

公司簡介
- Osiris Therapeutics, Inc.
- Kolon TissueGene, Inc.
- JCR Pharmaceuticals Co., Ltd.
- Anterogen Co. Ltd.
- Pharmicell Co., Inc.
- Stemedica Cell Technologies, Inc.
- Magellan
- Medipost Co., Ltd.
- Athersys Inc.
- Biorestorative Therapies Inc.
- Brainstorm Cell Limited.
- ViaCyte Inc.
- Cellular Biomedicine Group
- ANTEROGEN. CO, LTD.
- NuVasive Inc.
- RTI Surgical
- AlloSource

第9章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI2848

Stem Cell Therapy Market is estimated to be valued at USD 22.89 Bn in 2026 and is expected to reach USD 97.50 Bn by 2033, growing at a compound annual growth rate (CAGR) of 23.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 22.89 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	23.00%	2033 Value Projection:	USD 97.50 Bn

Stem cell therapy is a promising and emerging field in regenerative medicine that involves the use of stem cells and their derivatives to repair or regenerate damaged tissues and cells. Stem cells are found in all human beings from a very early stage of life. These have the unique ability to renew themselves through cell division and differentiate into a diverse range of specialized cell types. These cells hold great potential to treat many incurable diseases through transplantation or tissue regeneration. Stem cell research aims to harness the natural powers of stem cells to develop therapies that can cure various diseases like cancer, diabetes, heart disease, osteoarthritis and neurological disorders.

Market Dynamics

Global stem cell therapy market growth is driven by factors such as rising prevalence of chronic diseases, increasing success rates of stem cell therapies, rapid advancements in regenerative medicine, growing investments for research and development in stem cell therapies and approval of new therapies. However, high costs involved in stem cell research & development and therapeutic applications along with ethical issues related to embryonic stem cells can hamper the market growth. Emergence of new stem cell sources, development of advanced technology platforms for efficient production of stem cells, and application of artificial intelligence for faster development of customized stem cell therapies can offer opportunities for the market growth in the future. Providing affordable stem cell therapies globally and developing efficient techniques for stem cell banking can help to address unmet needs and expand the market reach.

Key Features of the Study

It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global stem cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., Stemedica Cell Technologies, Inc., Magellan, Medipost Co., Ltd, Athersys Inc., Biorestorative Therapies Inc., Brainstorm Cell Limited., ViaCyte Inc., Cellular Biomedicine Group, ANTEROGEN. C.O., LTD., NuVasive Inc., RTI Surgical, AlloSource.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global stem cell therapy market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cell therapy market.

Market Segmentation

Cell Source Insights (Revenue, USD Bn, 2021 - 2033)
Adult Stem Cells
Induced Pluripotent Stem Cells
Embryonic Stem Cells
Others
Application Insights (Revenue, USD Bn, 2021 - 2033)
Musculoskeletal Disorders
Wounds and Injuries
Cancer
Autoimmune Disorders
Others
End User Insights (Revenue, USD Bn, 2021 - 2033)
Hospitals
Cell Banks
Academic and Research Institutes
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Osiris Therapeutics, Inc.
Kolon TissueGene, Inc.
JCR Pharmaceuticals Co., Ltd.
Anterogen Co. Ltd.
Pharmicell Co., Inc.
Stemedica Cell Technologies, Inc.
Magellan
Medipost Co., Ltd.
Athersys Inc.
Biorestorative Therapies Inc.
Brainstorm Cell Limited.
ViaCyte Inc.
Cellular Biomedicine Group
ANTEROGEN. C.O., LTD.
NuVasive Inc.
RTI Surgical
AlloSource

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Cell Source
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Stem Cell Therapy Market, By Cell Source, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Adult Stem Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Induced Pluripotent Stem Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Embryonic Stem Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Stem Cell Therapy Market, By Application, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Musculoskeletal Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Wounds and Injuries
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Autoimmune Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Stem Cell Therapy Market, By End User, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cell Banks
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Academic and Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Stem Cell Therapy Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Osiris Therapeutics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Kolon TissueGene, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- JCR Pharmaceuticals Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Anterogen Co. Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pharmicell Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Stemedica Cell Technologies, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Magellan
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Medipost Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Athersys Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Biorestorative Therapies Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Brainstorm Cell Limited.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- ViaCyte Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cellular Biomedicine Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- ANTEROGEN. C.O., LTD.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- NuVasive Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- RTI Surgical
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AlloSource
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies